Cargando…
The Amyloid-Beta Clearance: From Molecular Targets to Glial and Neural Cells
The deposition of amyloid-beta (Aβ) plaques in the brain is one of the primary pathological characteristics of Alzheimer’s disease (AD). It can take place 20–30 years before the onset of clinical symptoms. The imbalance between the production and the clearance of Aβ is one of the major causes of AD....
Autores principales: | Cai, Wenjun, Wu, Tong, Chen, Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953441/ https://www.ncbi.nlm.nih.gov/pubmed/36830682 http://dx.doi.org/10.3390/biom13020313 |
Ejemplares similares
-
The role of amyloid beta clearance in cerebral amyloid angiopathy: more potential therapeutic targets
por: Qi, Xue-mei, et al.
Publicado: (2017) -
Amyloid-beta and Alzheimer’s disease: the role of neprilysin-2 in amyloid-beta clearance
por: Marr, Robert A., et al.
Publicado: (2014) -
Editorial on, “Amyloid-beta clearance in Alzheimer's disease”
por: Marr, Robert A.
Publicado: (2014) -
Glial phagocytic clearance in Parkinson’s disease
por: Tremblay, Marie-Eve, et al.
Publicado: (2019) -
Anticoagulants inhibit proteolytic clearance of plasma amyloid beta
por: Yang, Lu, et al.
Publicado: (2017)